fda warning letters glp-1 november 2025 Issues Letter to Pennsylvania Compounding Pharmacy Over Sterility Failures | The FDA Group posted on the topic Congress Introduces SAFE Drugs Act

Drugs may be on the formulary, but high cost tiers, prior authorizations, or restrictive access may reduce actual access

The bottom line Sleep disruption during perimenopause is real, it's common, and it has clear hormonal and physiological causes

HOS, Hongjingtian oral-solution

Bajwa Z., Acute treatment of migraine in adults

* Correspondence: Marco de Scordilli, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers